China News Service, May 5. According to Taiwan's "China Times News Network" report, the local epidemic in Taiwan is spreading, and the rapid screening reagents are in short supply, but there are black-hearted quick screening reagents flowing into the market.

A company in Taoyuan City falsely used the name of technology to make fake rapid screening reagents and sold them to private companies, hospitals and pharmacies, making illegal profits of more than 2.57 million yuan (NTD, the same below). The factory director and 2 company directors were charged with the crime.

  The Kaohsiung District Prosecutor's Office pointed out that Taoyuan Dingqun Company has been commissioned by the pharmaceutical company Sanyu since 2020 to manufacture "Sanyu New Coronavirus Antigen Rapid Screening Detection Reagents". Approved by the "Ministry of Health and Welfare", that is, privately obtain the "lysate solution" from other manufacturers, and then use the rapid screening reagent group produced by Sanyu without authorization, at a price ranging from 250 yuan to 350 yuan per group. Certain private companies, hospitals and pharmacies made a total of $2,570,512 in illegal profits.

Prosecutors charged the factory director and two responsible persons for crimes such as fraud, forgery of documents, and the Medical Equipment Management Act.

  In addition, the Taiwanese authorities' "Air Traffic Control Division" seized two biotechnology companies in Taichung City and Taoyuan City, and applied to the "Ministry of Health and Welfare" for approval of rapid screening reagents that require medical professionals to draw venous blood for testing, but added fingertips to the packaging without authorization. Blood collection needles, etc., under the cover of legality, are sold by distributors through online group buying and other channels at prices ranging from 150 yuan to 600 yuan per box.

Among them, the company in Taichung has sold more than 90 targets and has sold more than 230,000 doses.

  The "Airline Coordination Office" stated that the "Food and Drug Administration" currently only approves the antigen rapid screening reagents for nasal detection, and the antibody detection or antibody rapid screening of blood testing needs to be interpreted by medical personnel, and has not been approved for household use. The investigation bureau has a total of 2 companies More than 100,000 doses of finished products and more than 1.09 million doses of semi-finished products were seized and recovered.